幽门螺杆菌感染与胰岛素抵抗替代指标的相关性
Association between Helicobacter pylori Infection and Surrogate Markers of Insulin Resistance
DOI: 10.12677/acm.2024.14123072, PDF,    国家自然科学基金支持
作者: 陈圆圆, 刘卓琪, 方静雯, 丁岩冰*:扬州大学附属医院消化内科,江苏 扬州
关键词: 胰岛素抵抗替代指标幽门螺杆菌横断面研究NHANESSurrogate Markers of Insulin Resistance Helicobacter pylori Cross-Sectional Study NHANES
摘要: 目的:本研究基于美国国家健康与营养调查(National Health and Nutrition Examination Survey, NHANES)数据库,旨在探讨幽门螺杆菌(Helicobacter pylori, H. pylori)感染与胰岛素抵抗(Insulin Resistance, IR)替代指标之间的关系。方法:选取NHANES数据库1999~2000年横断面调查的参与者数据;采用单因素及多因素Logistic回归分析H. pylori感染的影响因素;通过多模型的Logistic回归分析H. pylori感染与IR替代指标的关联性,进行了亚组分析,以确保结果稳定。结果:最终纳入1446名参与者,H. pylori感染的总体患病率为41.8%,平均年龄为50.9岁。校正全部混杂因素后,甘油三酯葡萄糖(triglyceride glucose index, TyG)指数、甘油三酯葡萄糖–腰高比(triglyceride glucose-waist to height ratio, TyG-WHtR)和胰岛素抵抗代谢(metabolic score for insulin resistance, METS-IR)指数与H. pylori感染仍然呈现正相关。按年龄、性别、种族、吸烟、饮酒状况进行的亚组分析显示,无统计学显著性相互作用(P > 0.05)。结论:本研究结果表明,TyG指数、TyG-WHtR指数和METS-IR与H. pylori感染的风险有关,为未来研究提供了潜在的生物标志物。
Abstract: Objective: This study explores the relationship between Helicobacter pylori (H. pylori) infection and surrogate markers of insulin resistance (IR) using data from the National Health and Nutrition Examination Survey (NHANES) database. Methods: Data from the 1999~2000 NHANES cross-sectional survey were analyzed. Univariate and multivariate logistic regression models were used to identify factors influencing H. pylori infection. The association between H. pylori infection and IR surrogate markers was further assessed using multiple logistic regression models, with subgroup analyses conducted for robustness. Results: The study included 1446 participants, with an H. pylori infection prevalence of 41.8% and an average age of 50.9 years. After adjusting for confounders, the triglyceride glucose (TyG) index, triglyceride glucose-waist to height ratio (TyG-WHtR), and metabolic score for insulin resistance (METS-IR) index remained positively associated with H. pylori infection. Subgroup analyses by age, gender, ethnicity, smoking, and alcohol use revealed no statistically significant interactions (P > 0.05). Conclusion: These findings indicate that the TyG index, TyG-WHtR, and METS-IR are associated with an increased risk of H. pylori infection, highlighting their potential as biomarkers for further research.
文章引用:陈圆圆, 刘卓琪, 方静雯, 丁岩冰. 幽门螺杆菌感染与胰岛素抵抗替代指标的相关性[J]. 临床医学进展, 2024, 14(12): 237-248. https://doi.org/10.12677/acm.2024.14123072

参考文献

[1] Dunn, B.E., Cohen, H. and Blaser, M.J. (1997) Helicobacter pylori. Clinical Microbiology Reviews, 10, 720-741. [Google Scholar] [CrossRef] [PubMed]
[2] Li, Y., Choi, H., Leung, K., Jiang, F., Graham, D.Y. and Leung, W.K. (2023) Global Prevalence of Helicobacter pylori Infection between 1980 and 2022: A Systematic Review and Meta-Analysis. The Lancet Gastroenterology & Hepatology, 8, 553-564. [Google Scholar] [CrossRef] [PubMed]
[3] Lanas, A. and Chan, F.K.L. (2017) Peptic Ulcer Disease. The Lancet, 390, 613-624. [Google Scholar] [CrossRef] [PubMed]
[4] Wotherspoon, A.C. (1998) Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue and Helicobacter pylori. Annual Review of Medicine, 49, 289-299. [Google Scholar] [CrossRef] [PubMed]
[5] Crabtree, J.E., Shallcross, T.M., Heatley, R.V. and Wyatt, J.I. (1991) Mucosal Tumour Necrosis Factor Alpha and Interleukin-6 in Patients with Helicobacter pylori Associated Gastritis. Gut, 32, 1473-1477. [Google Scholar] [CrossRef] [PubMed]
[6] Rizwan, M., Alvi, A. and Ahmed, N. (2008) Novel Protein Antigen (JHP940) from the Genomic Plasticity Region of Helicobacter pylori Induces Tumor Necrosis Factor Alpha and Interleukin-8 Secretion by Human Macrophages. Journal of Bacteriology, 190, 1146-1151. [Google Scholar] [CrossRef] [PubMed]
[7] Lin, Q., Xu, H., Chen, X., Tang, G., Gu, L. and Wang, Y. (2015) Helicobacter pylori Cytotoxin-Associated Gene a Activates Tumor Necrosis Factor-α and Interleukin-6 in Gastric Epithelial Cells through P300/CBP-Associated Factor-Mediated Nuclear Factor-κB P65 Acetylation. Molecular Medicine Reports, 12, 6337-6345. [Google Scholar] [CrossRef] [PubMed]
[8] Moon, S., Park, Y., Jang, S., Kim, S., Song, D., Shin, D., et al. (2024) Interleukin-2 Improves Insulin Sensitivity through Hypothalamic Sympathetic Activation in Obese Mice. Journal of Neuroinflammation, 21, Article No. 250. [Google Scholar] [CrossRef] [PubMed]
[9] Imai, Y., Dobrian, A.D., Weaver, J.R., Butcher, M.J., Cole, B.K., Galkina, E.V., et al. (2013) Interaction between Cytokines and Inflammatory Cells in Islet Dysfunction, Insulin Resistance and Vascular Disease. Diabetes, Obesity and Metabolism, 15, 117-129. [Google Scholar] [CrossRef] [PubMed]
[10] Russo, B., Menduni, M., Borboni, P., Picconi, F. and Frontoni, S. (2021) Autonomic Nervous System in Obesity and Insulin-Resistance—The Complex Interplay between Leptin and Central Nervous System. International Journal of Molecular Sciences, 22, Article 5187. [Google Scholar] [CrossRef] [PubMed]
[11] Könner, A.C. and Brüning, J.C. (2012) Selective Insulin and Leptin Resistance in Metabolic Disorders. Cell Metabolism, 16, 144-152. [Google Scholar] [CrossRef] [PubMed]
[12] Yun, J. and Ko, S. (2021) Current Trends in Epidemiology of Cardiovascular Disease and Cardiovascular Risk Management in Type 2 Diabetes. Metabolism, 123, Article 154838. [Google Scholar] [CrossRef] [PubMed]
[13] Bielka, W., Przezak, A., Molęda, P., Pius-Sadowska, E. and Machaliński, B. (2024) Double Diabetes—When Type 1 Diabetes Meets Type 2 Diabetes: Definition, Pathogenesis and Recognition. Cardiovascular Diabetology, 23, Article No. 62. [Google Scholar] [CrossRef] [PubMed]
[14] Suzuki, M., Kanazawa, A., Shiba, M., Kojima, H. and Harano, Y. (2000) Insulin Resistance in Diabetic Microangiopathies. Journal of Diabetes and Its Complications, 14, 40-45. [Google Scholar] [CrossRef] [PubMed]
[15] Placzkowska, S., Pawlik-Sobecka, L., Kokot, I. and Piwowar, A. (2019) Indirect Insulin Resistance Detection: Current Clinical Trends and Laboratory Limitations. Biomedical Papers, 163, 187-199. [Google Scholar] [CrossRef] [PubMed]
[16] Li, Y., You, A., Tomlinson, B., Yue, L., Zhao, K., Fan, H., et al. (2021) Insulin Resistance Surrogates Predict Hypertension Plus Hyperuricemia. Journal of Diabetes Investigation, 12, 2046-2053. [Google Scholar] [CrossRef] [PubMed]
[17] Malek, M., Khamseh, M.E., Chehrehgosha, H., Nobarani, S. and Alaei-Shahmiri, F. (2021) Triglyceride Glucose-Waist to Height Ratio: A Novel and Effective Marker for Identifying Hepatic Steatosis in Individuals with Type 2 Diabetes Mellitus. Endocrine, 74, 538-545. [Google Scholar] [CrossRef] [PubMed]
[18] Wallace, T.M., Levy, J.C. and Matthews, D.R. (2004) Use and Abuse of HOMA Modeling. Diabetes Care, 27, 1487-1495. [Google Scholar] [CrossRef] [PubMed]
[19] Huang, J., Liu, Z., Ma, J., Liu, J., Lv, M., Wang, F., et al. (2022) The Association between Helicobacter pylori Seropositivity and Bone Mineral Density in Adults. Mediators of Inflammation, 2022, 1-7. [Google Scholar] [CrossRef] [PubMed]
[20] Huang, J., Zhang, K., Wang, F. and Tang, X. (2023) The Associations between Helicobacter pylori Immunoglobulin G Seropositivity and Body Mass Index in Adults. BMC Infectious Diseases, 23, Article No. 485. [Google Scholar] [CrossRef] [PubMed]
[21] Chen, Y., Yang, C., You, N. and Zhang, J. (2023) Relationship between Helicobacter pylori and Glycated Hemoglobin: A Cohort Study. Frontiers in Cellular and Infection Microbiology, 13, Article 1196338. [Google Scholar] [CrossRef] [PubMed]
[22] Zhu, X., Xiong, Y., Meng, X., Xu, H., Huo, L. and Deng, W. (2024) Association of Triglyceride-Glucose Index with Helicobacter pylori Infection and Mortality among the US Population. Diabetology & Metabolic Syndrome, 16, Article No. 187. [Google Scholar] [CrossRef] [PubMed]
[23] Park, S.H., Jeon, W.K., Kim, S.H., et al. (2005) Helicobacter pylori Eradication Has No Effect on Metabolic and Inflammatory Parameters. Journal of the National Medical Association, 97, 508-513.
[24] Chen, L., Chien, C., Lin, C. and Chien, R. (2021) Increased Glycated Hemoglobin but Decreased Cholesterol after a Loss of Helicobacter pylori Infection: A Community-Based Longitudinal Metabolic Parameters Follow-Up Study. Journal of Personalized Medicine, 11, Article 997. [Google Scholar] [CrossRef] [PubMed]
[25] Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W. and Xu, H. (2022) Trends in Insulin Resistance: Insights into Mechanisms and Therapeutic Strategy. Signal Transduction and Targeted Therapy, 7, Article No. 216. [Google Scholar] [CrossRef] [PubMed]
[26] Bretto, E., Frara, S., Armandi, A., Caviglia, G.P., Saracco, G.M., Bugianesi, E., et al. (2024) Helicobacter pylori in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander? Antibiotics, 13, Article 267. [Google Scholar] [CrossRef] [PubMed]
[27] Ji, R., Zuo, X., Yu, T., Gu, X., Li, Z., Zhou, C., et al. (2012) Mucosal Barrier Defects in Gastric Intestinal Metaplasia: In Vivo Evaluation by Confocal Endomicroscopy. Gastrointestinal Endoscopy, 75, 980-987. [Google Scholar] [CrossRef] [PubMed]